A detailed history of Segall Bryant & Hamill, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 44,701 shares of TMO stock, worth $22.9 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
44,701
Previous 20,531 117.72%
Holding current value
$22.9 Million
Previous $11.4 Million 143.53%
% of portfolio
0.39%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$531.86 - $624.21 $12.9 Million - $15.1 Million
24,170 Added 117.72%
44,701 $27.6 Million
Q2 2024

Aug 14, 2024

SELL
$541.52 - $599.02 $771,124 - $853,004
-1,424 Reduced 6.49%
20,531 $11.4 Million
Q1 2024

May 15, 2024

SELL
$528.82 - $599.43 $2.08 Million - $2.36 Million
-3,932 Reduced 15.19%
21,955 $12.8 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $63.1 Million - $78 Million
-146,268 Reduced 84.96%
25,887 $13.7 Million
Q3 2023

Nov 09, 2023

SELL
$498.29 - $574.41 $3.77 Million - $4.35 Million
-7,567 Reduced 4.21%
172,155 $87.1 Million
Q2 2023

Aug 11, 2023

SELL
$508.46 - $591.13 $904,041 - $1.05 Million
-1,778 Reduced 0.98%
179,722 $93.8 Million
Q1 2023

May 15, 2023

BUY
$535.0 - $604.82 $5.81 Million - $6.57 Million
10,860 Added 6.36%
181,500 $105 Million
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $1.54 Million - $1.81 Million
-3,171 Reduced 1.82%
170,640 $94 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $11 Million - $13.1 Million
-21,657 Reduced 11.08%
173,811 $88.2 Million
Q2 2022

Aug 15, 2022

BUY
$500.9 - $612.21 $10 Million - $12.3 Million
20,051 Added 11.43%
195,468 $106 Million
Q1 2022

May 13, 2022

SELL
$524.0 - $644.92 $748,272 - $920,945
-1,428 Reduced 0.81%
175,417 $104 Million
Q4 2021

Feb 14, 2022

BUY
$569.0 - $667.24 $396,593 - $465,066
697 Added 0.4%
176,845 $118 Million
Q3 2021

Nov 03, 2021

BUY
$509.53 - $609.78 $337,308 - $403,674
662 Added 0.38%
176,148 $101 Million
Q2 2021

Aug 12, 2021

BUY
$441.0 - $508.24 $1.7 Million - $1.96 Million
3,856 Added 2.25%
175,486 $88.5 Million
Q1 2021

May 13, 2021

SELL
$439.85 - $518.83 $2.86 Million - $3.37 Million
-6,497 Reduced 3.65%
171,630 $78.3 Million
Q4 2020

Feb 12, 2021

SELL
$435.06 - $527.66 $3.27 Million - $3.97 Million
-7,517 Reduced 4.05%
178,127 $83 Million
Q3 2020

Nov 13, 2020

BUY
$359.77 - $441.52 $2.91 Million - $3.57 Million
8,083 Added 4.55%
185,644 $82 Million
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $432,064 - $568,873
-1,570 Reduced 0.88%
177,561 $64.3 Million
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $1.41 Million - $1.88 Million
-5,535 Reduced 3.0%
179,131 $50.8 Million
Q4 2019

Feb 11, 2020

SELL
$271.93 - $328.04 $206,394 - $248,982
-759 Reduced 0.41%
184,666 $60 Million
Q3 2019

Nov 12, 2019

SELL
$268.46 - $305.43 $2.84 Million - $3.23 Million
-10,561 Reduced 5.39%
185,425 $54 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $194,677 - $223,435
-756 Reduced 0.38%
195,986 $0
Q1 2019

May 15, 2019

SELL
$212.17 - $273.72 $639,692 - $825,265
-3,015 Reduced 1.51%
196,742 $0
Q4 2018

Feb 15, 2019

BUY
$208.47 - $251.98 $726,309 - $877,898
3,484 Added 1.78%
199,757 $44.7 Million
Q3 2018

Nov 14, 2018

BUY
$205.57 - $244.32 $1.75 Million - $2.08 Million
8,493 Added 4.52%
196,273 $0
Q2 2018

Aug 08, 2018

BUY
$203.14 - $219.53 $3.51 Million - $3.8 Million
17,303 Added 10.15%
187,780 $0
Q1 2018

May 16, 2018

SELL
$192.98 - $224.11 $2.27 Million - $2.63 Million
-11,748 Reduced 6.45%
170,477 $0
Q4 2017

Feb 15, 2018

BUY
$182.03 - $200.37 $6.33 Million - $6.97 Million
34,763 Added 23.57%
182,225 $0
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $25.3 Million - $28.6 Million
147,462
147,462 $0

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.